Humanetics Corporation Presents Data on Drug to Protect Cardiac Cells Against Toxicity From Space-Like Radiation
January 30, 2018 - The National Aeronautics and Space Administration awarded the grant to evaluate Humanetics Corporation's investigational new drug, BIO 300. StemoniX partnered with Humanetics for the research.
StemoniX featured in Technology Networks
January 30, 2018 - MicroTissue: Transforming Drug Discovery. Following their recent press release, we spoke to Ping Yeh, CEO of StemoniX, to learn more about the company and their mission. With an aim to accelerate and optimize drug discovery and development, StemoniX creates ‘ready-to-use’ microtissue plates that mimic the native organ tissue.
StemoniX is a Medical Alley Award Winner!
April 24, 2018 - Spring came just in time for the 2018 Medical Alley Annual Dinner, held on April 24 at the Depot MPLS. Over 750 Medical Alley members – sans winter coats – joined together to celebrate a stellar year that was for our community and to look ahead at what’s to come in the global epicenter of health innovation and care.
StemoniX microHeart brings home Edison Gold!
May 31, 2018 - microHeart is stem cell-derived biologically accurate human cardiac microtissue for testing drug effects on the heart before actual use by people. This leap forward enables the discovery of safe, effective drugs and personalized medicine, while decreasing adverse drug events and late-stage drug failures.
StemoniX featured in Select Science
June 13, 2018 - 3D Human Spheroids as a Predictive Model in Drug Discovery
Dr. Ryan Gordon, VP of Business Development and Commercialization at StemoniX, discusses the potential of human spheroids in predictive assays.
CONNECT Announces Winners of 2018 Most Innovative New Product Awards
September 3, 2019 - Seven San Diego companies selected as recipients of annual award. Mark Dankberg inducted into CONNECT Entrepreneur Hall of Fame.